Xeris Pharmaceuticals | XERS - Loan Capital



Xeris Pharmaceuticals reported $218.63M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Adcock Ingram Holdings ZAR 220.08M 18M Dec/2024
Celltrion KRW 114.04B 8.35B Mar/2025
Cspc Pharmaceutical CNY 56.14M 10.18M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd 20M 0 Mar/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Kangmei Pharma CNY 84.24M 3.67M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 101.36M 20.86M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.76M 150K Dec/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 52.8M 9.51M Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Pharma Mar EUR 37.57M 2.66M Jun/2025
Qiagen NV USD 884.85M 467.8M Jun/2025
Sartorius EUR 4.09B 112.3M Jun/2025
Sino Biopharmaceutical CNY 2.08B 915.48M Dec/2024
Supernus Pharmaceuticals USD 0 0 Dec/2024
Tilray USD 316.63M 15.02M Nov/2024
Zz Pientze Pharmaceu 196.31M 8.23M Jun/2025